Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:clinical_trial |
Phase 1
|
| gptkbp:developed_by |
gptkb:Bio_NTech
|
| https://www.w3.org/2000/01/rdf-schema#label |
BNT162b13
|
| gptkbp:platform |
m RNA technology
|
| gptkbp:regulatory_compliance |
under investigation
|
| gptkbp:related_to |
gptkb:BNT162b1
|
| gptkbp:route_of_administration |
intramuscular
|
| gptkbp:targeted_antigen |
gptkb:SARS-Co_V-2_spike_protein
|
| gptkbp:targets |
gptkb:COVID-19
|
| gptkbp:type |
gptkb:vaccine
|
| gptkbp:bfsParent |
gptkb:Bio_NTech
|
| gptkbp:bfsLayer |
5
|